Clinical Trials Browser

NIH × Inflammatory Breast Neoplasms × Doxorubicin × Clear all

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms